Webinar: Rare diseases: Natural history studies for drug development
1:00:36
Related Videos
In Therapeutic Webinars
-
Play video Implementing novel development strategies for cell & gene therapy clinical trials
Implementing novel development strategies for cell & gene therapy clinical trials
1:00:47
-
Play video Reflections on paediatric assent: Have we outgrown this concept?
Reflections on paediatric assent: Have we outgrown this concept?
In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.
1:02:52
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Navigating the future of cell & gene therapy - the potential for broader indication
Navigating the future of cell & gene therapy - the potential for broader indication
58:33
